These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Expression of cyclooxygenase in bladder transitional cell carcinoma].
    Author: Wang KJ, Li H, Wei Q, Yang YR.
    Journal: Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815.
    Abstract:
    OBJECTIVE: To evaluate the role of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) in the development of bladder transitional cell carcinoma. METHODS: Thirty-four specimens were obtained from patients with bladder transitional carcinoma, and 7 specimens of normal bladder tissues were obtained from renal transplantation donors. Immunohistochemistry and RT-PCR were performed to study the expression of COX-1 and COX-2. RESULTS: No marked expression of COX-2 was observed in the normal bladder, but higher level of COX-2 expression was noted in the malignant cells. The extent and intensity of COX-2 expression in cancer cells were statistically greater than those in the cells from normal bladder tissue. Correlation between COX-2 expression and progression of bladder transitional cell carcinoma was observed. COX-2 expression was significantly higher in Grade 3 bladder transitional cell carcinoma than in Grades 1 and 2 (P < 0.001). There was no significant difference in COX-2 expression level between the bladder transitional cell carcinomas at different clinical stages (P > 0.05). The expression of COX-1 was seen in some bladder transitional cell carcinoma and normal bladder. CONCLUSION: COX-2 might be of significance to the proliferation and development of bladder transitional cell carcinoma.
    [Abstract] [Full Text] [Related] [New Search]